Key result
Extreme obesity (BMI >32) was associated with a higher rate of 6-month target vessel revascularization following PCI compared to lower BMI categories.
Why the study?
Does obesity affect ischemic outcomes and bleeding in patients undergoing coronary stent placement with GP IIb/IIIa inhibitors?
Cohort
Yes
Does obesity affect ischemic outcomes and bleeding in patients undergoing coronary stent placement with GP IIb/IIIa inhibitors?
Extreme obesity is associated with increased 6-month target vessel revascularization following coronary stenting, though obesity overall is associated with less major bleeding.
Answers are grounded in this paper and cite their sources.
Extreme obesity was associated with higher TVR post-stenting; leaves open whether BMI-targeted strategies improve outcomes in younger patients.
OBJECTIVES: We analyzed the relationship of obesity, determined by body mass index (BMI), to short- and long-term outcomes in the TARGET trial. BACKGROUND: : Previous studies have conflicting findings regarding the relationship of BMI to outcomes following percutaneous coronary intervention (PCI). METHODS: The TARGET trial studied the use of glycoprotein (GP) IIb/IIIa inhibition in patients undergoing planned coronary stent placement. RESULTS: Eighty-one percent of all patients were overweight (BMI > 25), 36% were obese (BMI > 30), and United States patients were more frequently obese (38.7% vs. 25.8%, P < 0.001). Obese patients had a similar 30-day ischemic event rate compared with nonobese patients, but less major bleeding (0.4% vs. 1.1%, P = 0.013). Six-month death and myocardial infarction rates were similar in obese and nonobese patients. There was a J-shaped relationship between 6-month target vessel revascularization (TVR) and BMI with the lowest incidence of TVR at BMI 27.5. Six-month TVR was higher in the morbidly (BMI > 35) obese (12.4% vs 8.7%, P < 0.05). In extremely (BMI > 32) obese patients, this relationship was more significant (TVR 11.3% vs. 8.5%, P = 0.007), particularly in patients <65 years of age (TVR 12.3% vs. 8.4%, P = 0.003). CONCLUSION: The majority of patients undergoing PCI are overweight, especially in the United States. Extreme obesity is associated with a significant increase in TVR following intent-to-stent PCI, especially in patients <65 years of age. With routine use of GP IIb/IIIa inhibitors, other long- and short-term ischemic events are similar in obese and nonobese patients. However, obese patients have significantly less major bleeding.
No takes yet. Share an insight, caveat, or question.
Martin et al. (2006) conducted a cohort in Coronary artery disease requiring stent placement. Extreme obesity (BMI > 32) vs. Non-extremely obese patients was evaluated on 6-month target vessel revascularization (TVR) (p=0.007). Extreme obesity (BMI >32) was associated with a higher rate of 6-month target vessel revascularization following PCI compared to lower BMI categories.
Synapse has enriched 10 related papers. Consider them for comparative context: